Ligand id: 7373

Name: AlprolixTM

No information available.
Summary of Clinical Use
Designated as an orphan drug by the US FDA, this drug may be used as a prophylactic to reduce bleeding episodes in patients suffering from Hemophilia B. The benefit of this drug is its extended half-life compared to previous treatments, meaning that patients require less frequent injections.
Mechanism Of Action and Pharmacodynamic Effects
Replaces the factor IX missing in hemophilia B patients, to restore clotting function and reduce pathological bleeding events.